BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38811264)

  • 1. Pneumococcal antibody response in children with recurrent respiratory tract infections: A descriptive study.
    Ceuppens F; Meyts I; Bossuyt X; De Boeck K
    Arch Pediatr; 2024 May; ():. PubMed ID: 38811264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of previous vaccination with pneumococcal conjugate vaccine on pneumococcal polysaccharide vaccine antibody responses.
    Schaballie H; Wuyts G; Dillaerts D; Frans G; Moens L; Proesmans M; Vermeulen F; De Boeck K; Meyts I; Bossuyt X
    Clin Exp Immunol; 2016 Aug; 185(2):180-9. PubMed ID: 26939935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific antibody deficiency with normal immunoglobulin concentration in children with recurrent respiratory infections.
    Quezada A; Norambuena X; Inostroza J; Rodríguez J
    Allergol Immunopathol (Madr); 2015; 43(3):292-7. PubMed ID: 25498324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to pneumococcal polysaccharide vaccine in children with asthma, and children with recurrent respiratory infections, and healthy children.
    Quezada A; Maggi L; Norambuena X; Inostroza J; Quevedo F
    Allergol Immunopathol (Madr); 2016; 44(4):376-81. PubMed ID: 27255476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections.
    Hidalgo H; Moore C; Leiva LE; Sorensen RU
    Ann Allergy Asthma Immunol; 1996 Apr; 76(4):341-6. PubMed ID: 8612116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin isotype-specific antibody responses to pneumococcal polysaccharide vaccine in patients with recurrent bacterial respiratory tract infections.
    Sanders LA; Rijkers GT; Tenbergen-Meekes AM; Voorhorst-Ogink MM; Zegers BJ
    Pediatr Res; 1995 Jun; 37(6):812-9. PubMed ID: 7651768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficient IgA and IgG2 anti-pneumococcal antibody levels and response to vaccination in otitis prone children.
    Dhooge IJ; van Kempen MJ; Sanders LA; Rijkers GT
    Int J Pediatr Otorhinolaryngol; 2002 Jun; 64(2):133-41. PubMed ID: 12049826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-immunization pneumococcal antibody titers and IgG subclasses.
    Sorensen RU; Hidalgo H; Moore C; Leiva LE
    Pediatr Pulmonol; 1996 Sep; 22(3):167-73. PubMed ID: 8893255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining Polysaccharide Antibody Deficiency: Measurement of Anti-Pneumococcal Antibodies and Anti-Salmonella typhi Antibodies in a Cohort of Patients with Recurrent Infections.
    Bucciol G; Schaballie H; Schrijvers R; Bosch B; Proesmans M; De Boeck K; Boon M; Vermeulen F; Lorent N; Dillaerts D; Kantsø B; Jørgensen CS; Emonds MP; Bossuyt X; Moens L; Meyts I
    J Clin Immunol; 2020 Jan; 40(1):105-113. PubMed ID: 31705452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical relevance of IgM and IgA anti-pneumococcal polysaccharide ELISA assays in patients with suspected antibody deficiency.
    Janssen LMA; Heron M; Murk JL; Leenders ACAP; Rijkers GT; de Vries E
    Clin Exp Immunol; 2021 Aug; 205(2):213-221. PubMed ID: 33877708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of Typhim Vi IgG as a Diagnostic Tool to Determine Anti-polysaccharide Antibody Production Deficiency in Children.
    Guevara-Hoyer K; Gil C; Parker AR; Williams LJ; Orte C; Rodriguez de la Peña A; Ochoa-Grullón J; Rodriguez De Frias E; García IS; García-Gómez S; Recio MJ; Fernández-Arquero M; Pérez de Diego R; Ramos JT; Sánchez-Ramón S
    Front Immunol; 2019; 10():654. PubMed ID: 31001267
    [No Abstract]   [Full Text] [Related]  

  • 12. Defective antipneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections.
    Sanders LA; Rijkers GT; Kuis W; Tenbergen-Meekes AJ; de Graeff-Meeder BR; Hiemstra I; Zegers BJ
    J Allergy Clin Immunol; 1993 Jan; 91(1 Pt 1):110-9. PubMed ID: 8423268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective deficiency in pneumococcal antibody response in children with recurrent infections.
    Epstein MM; Gruskay F
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):125-31. PubMed ID: 7648376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective antibody deficiency and its relation to the IgG2 and IgG3 subclass titers in recurrent respiratory infections.
    Sherkat R; Shoaei P; Parvaneh N; Babak A; Kassaian N
    Iran J Immunol; 2013 Mar; 10(1):55-60. PubMed ID: 23502339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical correlates of response to pneumococcal immunization.
    Akikusa JD; Kemp AS
    J Paediatr Child Health; 2001 Aug; 37(4):382-7. PubMed ID: 11532059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations.
    Sorensen RU; Leiva LE; Javier FC; Sacerdote DM; Bradford N; Butler B; Giangrosso PA; Moore C
    J Allergy Clin Immunol; 1998 Aug; 102(2):215-21. PubMed ID: 9723664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Serologic Response to the 23-valent Polysaccharide Pneumococcal Vaccine in Children and Teens with Recurrent Upper Respiratory Tract Infections and Selective Antibody Deficiency.
    Estrada J; Najera M; Pounds N; Catano G; Infante AJ
    Pediatr Infect Dis J; 2016 Feb; 35(2):205-8. PubMed ID: 26517331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children.
    Kamchaisatian W; Wanwatsuntikul W; Sleasman JW; Tangsinmankong N
    J Allergy Clin Immunol; 2006 Dec; 118(6):1336-41. PubMed ID: 17157665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The total IgM, IgA and IgG antibody responses to pneumococcal polysaccharide vaccination (Pneumovax®23) in a healthy adult population and patients diagnosed with primary immunodeficiencies.
    Parker AR; Park MA; Harding S; Abraham RS
    Vaccine; 2019 Feb; 37(10):1350-1355. PubMed ID: 30737041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.